X

Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

New report shows 200 medicines in development for heart disease and stroke

By Andrew Powaleny  |    February 20, 2018
Cardiovascular disease, which includes heart disease and stroke, is the leading cause of death in the United States, accounting for one out of every three deaths. According to the American Heart...   Read More

Guest post: Help celebrate #ChampionsofScience: Nominate a pioneering researcher for the 2018 Dr. Paul Janssen Award for Biomedical Research

By Guest Contributor  |    January 29, 2018
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest...   Read More

Innovation comes in many forms, including new and expanded uses of existing medicines

By Emma Van Hook  |    January 29, 2018
2017 was a record-breaking year for new drug approvals, with the U.S. Food and Drug Administration (FDA) approving 56 new drugs and biologics. But the innovation did not stop there. As the FDA...   Read More

New report and event examine the new era of vaccines

By Andrew Powaleny  |    November 9, 2017
Today, leading minds will come together for an in-depth conversation centered on vaccines – their critical role in warding off disease, the innovative science powering breakthroughs in their...   Read More

A new era in cancer

By Andrew Powaleny  |    November 1, 2017
The last few years have seen unparalleled progress in cancer care, with breakthrough research driving major advances in diagnosis and treatment. Next week, on Wednesday, November 8, leading minds...   Read More

PhRMA, member companies and NIH create public-private partnership for immuno-oncology

By Andrew Powaleny  |    October 12, 2017
The rapid pace of scientific advances has helped usher in a new era of medicine for cancer patients over the last decade. This morning, the National Institutes of Health (NIH) took a significant...   Read More

2017 Research & Hope Awards honor innovators in mental health

By Hannah Mooney  |    October 10, 2017
Mental health disorders are a heavy human and economic burden in the United States. More than 40 million people across the country are impacted by mental illness, and it’s estimated that in any...   Read More

What they are saying: Study on cancer R&D costs is not an accurate representation of marketplace

By Holly Campbell  |    September 12, 2017
This post has been updated as of 10/2/2017 A recent study published in JAMA Internal Medicine provides flawed and inaccurate estimates of the significant research and development (R&D) investments...   Read More

How biopharmaceutical collaboration is driving a new era of medicine

By Andrew Powaleny  |    September 7, 2017
Biopharmaceutical innovation, coupled with technological advancements, has brought a new era of medicine transforming how we research and develop new medicines to benefit patients.   Read More

New PhRMA resources chock full of biopharma industry facts

By John Corea  |    July 20, 2017
Did you know that PhRMA member companies invested $65.5 billion in research and development (R&D) in 2016? Or that combined spending on brand medicines, generics and the supply chain account for...   Read More

Search the Catalyst

View Posts by Topic

see all

Subscribe to Email Updates